In order to achieve the newly proposed sustainable development goal of ending the HIV/AIDS epidemic by 2030 [36], and with evidence showing positive clinical impact of ART for patients with CD4 count > 500 cells/μl [37], a policy shift toward recommendation of ART initiation for all HIV infected individuals regardless of CD4 count has recently been announced by WHO [38]. The gene discussed is CD4; the disease is AIDS.